Venous thromboembolism (VTE) in Europe - The number of VTE events and associated morbidity and mortality

Alexander T. Cohen, Giancarlo Agnelli, Frederick A. Anderson, Juan I. Arcelus, David Bergqvist, Josef G. Brecht, Ian A. Greer, John A. Heit, Julia L. Hutchinson, Ajay K. Kakkar, Dominique Mottier, Emmanuel Oger, Meyer Michel Samama, Michael Spannagl

Research output: Contribution to journalArticle

879 Citations (Scopus)

Abstract

Venous thromboembolism (VTE) is often asymptomatic, misdiagnosed, and unrecognized at death, and there is a lack of routine postmortem examinations. These factors are thought to result in marked underestimates of VTE incidence. The objective of our study was to estimate the total burden of VTE within the European Union (EU) per annum. An epidemiological model was constructed to estimate the number of community- and hospital-acquired incidents and recurrent cases (attack rate) of non-fatal VTE and VTE-related deaths, as well as incident and prevalent cases of post-thrombotic syndrome (PTS) and chronic thromboembolic pulmonary hypertension (PH) occurring in the EU per annum. Individual models were developed for six EU countries. The models were populated with data from published literature and, where necessary, expert opinions. The findings were tested using probabilistic sensitivity analyses. The estimated total number of symptomatic VTE events (range based on probabilistic sensitivity analysis) per annum within the six EU countries was 465,715 (404,664-538,189) cases of deep-vein thrombosis, 295,982 (242,450-360,363) cases of pulmonary embolism (PE), and 370,012 (300,193-483,108) VTE-related deaths. Of these deaths, an estimated 27,473 (7%) were diagnosed as being antemortem; 126,145 (34%) were sudden fatal PE, and 217,394 (59%) followed undiagnosed PE. Almost three-quarters of all VTE-related deaths were from hospital-acquired VTE. VTE is a major health problem in the EU, with over one million VTE events or deaths per annum in the six countries examined. Given the availability of effective VTE prophylaxis, many of these events and deaths could have been prevented. These results have important implications for the allocation of healthcare resources.

Original languageEnglish (US)
Pages (from-to)756-764
Number of pages9
JournalThrombosis and Haemostasis
Volume98
Issue number4
DOIs
StatePublished - Oct 2007

Fingerprint

Venous Thromboembolism
Morbidity
Mortality
European Union
Pulmonary Embolism
Resource Allocation
Community Hospital
Expert Testimony
Diagnostic Errors
Pulmonary Hypertension
Venous Thrombosis
Autopsy
Delivery of Health Care

Keywords

  • Deep-vein thrombosis
  • Post-thrombotic syndrome
  • Pulmonary embolism
  • Pulmonary hypertension
  • Venous thromboembolism
  • VTE prophylaxis

ASJC Scopus subject areas

  • Hematology

Cite this

Cohen, A. T., Agnelli, G., Anderson, F. A., Arcelus, J. I., Bergqvist, D., Brecht, J. G., ... Spannagl, M. (2007). Venous thromboembolism (VTE) in Europe - The number of VTE events and associated morbidity and mortality. Thrombosis and Haemostasis, 98(4), 756-764. https://doi.org/10.1160/TH07-03-0212

Venous thromboembolism (VTE) in Europe - The number of VTE events and associated morbidity and mortality. / Cohen, Alexander T.; Agnelli, Giancarlo; Anderson, Frederick A.; Arcelus, Juan I.; Bergqvist, David; Brecht, Josef G.; Greer, Ian A.; Heit, John A.; Hutchinson, Julia L.; Kakkar, Ajay K.; Mottier, Dominique; Oger, Emmanuel; Samama, Meyer Michel; Spannagl, Michael.

In: Thrombosis and Haemostasis, Vol. 98, No. 4, 10.2007, p. 756-764.

Research output: Contribution to journalArticle

Cohen, AT, Agnelli, G, Anderson, FA, Arcelus, JI, Bergqvist, D, Brecht, JG, Greer, IA, Heit, JA, Hutchinson, JL, Kakkar, AK, Mottier, D, Oger, E, Samama, MM & Spannagl, M 2007, 'Venous thromboembolism (VTE) in Europe - The number of VTE events and associated morbidity and mortality', Thrombosis and Haemostasis, vol. 98, no. 4, pp. 756-764. https://doi.org/10.1160/TH07-03-0212
Cohen, Alexander T. ; Agnelli, Giancarlo ; Anderson, Frederick A. ; Arcelus, Juan I. ; Bergqvist, David ; Brecht, Josef G. ; Greer, Ian A. ; Heit, John A. ; Hutchinson, Julia L. ; Kakkar, Ajay K. ; Mottier, Dominique ; Oger, Emmanuel ; Samama, Meyer Michel ; Spannagl, Michael. / Venous thromboembolism (VTE) in Europe - The number of VTE events and associated morbidity and mortality. In: Thrombosis and Haemostasis. 2007 ; Vol. 98, No. 4. pp. 756-764.
@article{c2adc1f480f54f0eb305bb7fe7d0813d,
title = "Venous thromboembolism (VTE) in Europe - The number of VTE events and associated morbidity and mortality",
abstract = "Venous thromboembolism (VTE) is often asymptomatic, misdiagnosed, and unrecognized at death, and there is a lack of routine postmortem examinations. These factors are thought to result in marked underestimates of VTE incidence. The objective of our study was to estimate the total burden of VTE within the European Union (EU) per annum. An epidemiological model was constructed to estimate the number of community- and hospital-acquired incidents and recurrent cases (attack rate) of non-fatal VTE and VTE-related deaths, as well as incident and prevalent cases of post-thrombotic syndrome (PTS) and chronic thromboembolic pulmonary hypertension (PH) occurring in the EU per annum. Individual models were developed for six EU countries. The models were populated with data from published literature and, where necessary, expert opinions. The findings were tested using probabilistic sensitivity analyses. The estimated total number of symptomatic VTE events (range based on probabilistic sensitivity analysis) per annum within the six EU countries was 465,715 (404,664-538,189) cases of deep-vein thrombosis, 295,982 (242,450-360,363) cases of pulmonary embolism (PE), and 370,012 (300,193-483,108) VTE-related deaths. Of these deaths, an estimated 27,473 (7{\%}) were diagnosed as being antemortem; 126,145 (34{\%}) were sudden fatal PE, and 217,394 (59{\%}) followed undiagnosed PE. Almost three-quarters of all VTE-related deaths were from hospital-acquired VTE. VTE is a major health problem in the EU, with over one million VTE events or deaths per annum in the six countries examined. Given the availability of effective VTE prophylaxis, many of these events and deaths could have been prevented. These results have important implications for the allocation of healthcare resources.",
keywords = "Deep-vein thrombosis, Post-thrombotic syndrome, Pulmonary embolism, Pulmonary hypertension, Venous thromboembolism, VTE prophylaxis",
author = "Cohen, {Alexander T.} and Giancarlo Agnelli and Anderson, {Frederick A.} and Arcelus, {Juan I.} and David Bergqvist and Brecht, {Josef G.} and Greer, {Ian A.} and Heit, {John A.} and Hutchinson, {Julia L.} and Kakkar, {Ajay K.} and Dominique Mottier and Emmanuel Oger and Samama, {Meyer Michel} and Michael Spannagl",
year = "2007",
month = "10",
doi = "10.1160/TH07-03-0212",
language = "English (US)",
volume = "98",
pages = "756--764",
journal = "Thrombosis and Haemostasis",
issn = "0340-6245",
publisher = "Schattauer GmbH",
number = "4",

}

TY - JOUR

T1 - Venous thromboembolism (VTE) in Europe - The number of VTE events and associated morbidity and mortality

AU - Cohen, Alexander T.

AU - Agnelli, Giancarlo

AU - Anderson, Frederick A.

AU - Arcelus, Juan I.

AU - Bergqvist, David

AU - Brecht, Josef G.

AU - Greer, Ian A.

AU - Heit, John A.

AU - Hutchinson, Julia L.

AU - Kakkar, Ajay K.

AU - Mottier, Dominique

AU - Oger, Emmanuel

AU - Samama, Meyer Michel

AU - Spannagl, Michael

PY - 2007/10

Y1 - 2007/10

N2 - Venous thromboembolism (VTE) is often asymptomatic, misdiagnosed, and unrecognized at death, and there is a lack of routine postmortem examinations. These factors are thought to result in marked underestimates of VTE incidence. The objective of our study was to estimate the total burden of VTE within the European Union (EU) per annum. An epidemiological model was constructed to estimate the number of community- and hospital-acquired incidents and recurrent cases (attack rate) of non-fatal VTE and VTE-related deaths, as well as incident and prevalent cases of post-thrombotic syndrome (PTS) and chronic thromboembolic pulmonary hypertension (PH) occurring in the EU per annum. Individual models were developed for six EU countries. The models were populated with data from published literature and, where necessary, expert opinions. The findings were tested using probabilistic sensitivity analyses. The estimated total number of symptomatic VTE events (range based on probabilistic sensitivity analysis) per annum within the six EU countries was 465,715 (404,664-538,189) cases of deep-vein thrombosis, 295,982 (242,450-360,363) cases of pulmonary embolism (PE), and 370,012 (300,193-483,108) VTE-related deaths. Of these deaths, an estimated 27,473 (7%) were diagnosed as being antemortem; 126,145 (34%) were sudden fatal PE, and 217,394 (59%) followed undiagnosed PE. Almost three-quarters of all VTE-related deaths were from hospital-acquired VTE. VTE is a major health problem in the EU, with over one million VTE events or deaths per annum in the six countries examined. Given the availability of effective VTE prophylaxis, many of these events and deaths could have been prevented. These results have important implications for the allocation of healthcare resources.

AB - Venous thromboembolism (VTE) is often asymptomatic, misdiagnosed, and unrecognized at death, and there is a lack of routine postmortem examinations. These factors are thought to result in marked underestimates of VTE incidence. The objective of our study was to estimate the total burden of VTE within the European Union (EU) per annum. An epidemiological model was constructed to estimate the number of community- and hospital-acquired incidents and recurrent cases (attack rate) of non-fatal VTE and VTE-related deaths, as well as incident and prevalent cases of post-thrombotic syndrome (PTS) and chronic thromboembolic pulmonary hypertension (PH) occurring in the EU per annum. Individual models were developed for six EU countries. The models were populated with data from published literature and, where necessary, expert opinions. The findings were tested using probabilistic sensitivity analyses. The estimated total number of symptomatic VTE events (range based on probabilistic sensitivity analysis) per annum within the six EU countries was 465,715 (404,664-538,189) cases of deep-vein thrombosis, 295,982 (242,450-360,363) cases of pulmonary embolism (PE), and 370,012 (300,193-483,108) VTE-related deaths. Of these deaths, an estimated 27,473 (7%) were diagnosed as being antemortem; 126,145 (34%) were sudden fatal PE, and 217,394 (59%) followed undiagnosed PE. Almost three-quarters of all VTE-related deaths were from hospital-acquired VTE. VTE is a major health problem in the EU, with over one million VTE events or deaths per annum in the six countries examined. Given the availability of effective VTE prophylaxis, many of these events and deaths could have been prevented. These results have important implications for the allocation of healthcare resources.

KW - Deep-vein thrombosis

KW - Post-thrombotic syndrome

KW - Pulmonary embolism

KW - Pulmonary hypertension

KW - Venous thromboembolism

KW - VTE prophylaxis

UR - http://www.scopus.com/inward/record.url?scp=35048860791&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35048860791&partnerID=8YFLogxK

U2 - 10.1160/TH07-03-0212

DO - 10.1160/TH07-03-0212

M3 - Article

C2 - 17938798

AN - SCOPUS:35048860791

VL - 98

SP - 756

EP - 764

JO - Thrombosis and Haemostasis

JF - Thrombosis and Haemostasis

SN - 0340-6245

IS - 4

ER -